Prognosis in newborns after mother's preeclampsia;Pronostic des nouveau-nés de mère prééclamptique

Annales Francaises d'Anesthesie et de Reanimation

Volumn 29, Issue 5, 2010, Pages

  Zupan Simunek, V ^a  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Cerebral palsy; Follow up; Neonatal encephalopathy; Perinatal outcome; Preterm infants

Indexed keywords

ARTICLE; BRAIN DISEASE; FATTY ACID OXIDATION; FATTY LIVER; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; NEWBORN CARE; PERINATAL ASPHYXIA; PERINATAL MORBIDITY; PERINATAL MORTALITY; PERINATAL PERIOD; PREECLAMPSIA; PREMATURITY; PROGNOSIS; FEMALE; INFANT, NEWBORN, DISEASES; NEWBORN; PREGNANCY;

FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS;

EID: 77953536474     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annfar.2010.03.013     Document Type: Article

References (67)

1. Villar J., Carroli G., Wojdyla D., Abalos E., Giordano D., Ba'aqeel H., et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?. Am J Obstet Gynecol 2006, 194:921-931.
2. Zeitlin J., Ancel P.Y., Larroque B., Kaminski M. Fetal sex and indicated very preterm birth: results of the EPIPAGE study. Am J Obstet Gynecol 2004, 190:1322-1325. EPIPAGE Study.
3. Larroque B., Breart G., Kaminski M., Dehan M., Andre M., Burguet A., et al. Survival of very preterm infants: Epipage, a population based cohort study. Arch Dis Child Fetal Neonatal Ed 2004, 89:F139-F144.
4. Larroque B., Ancel P.Y., Marret S., Marchand L., André M., Arnaud C., et al. Neurodevelopmental disabilities and special care of 5-year-old-children born before 33 weeks of gestation (the Epipage study): a longitudinal cohort study. Lancet 2008, 371:813-820.
5. Ngoc N.T., Merialdi M., Abdel-Aleem H., Carroli G., Purwar M., Zavaleta N., et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. Bull World Health Organ 2006, 84:699-705.
6. Spinillo A., Chiara A., Bergante C., Biancheri D., Fabiana D., Fazzi E. Obstetric risk factors and persistent increases in brain parenchymal echogenicity in preterm infants. BJOG 2004, 111:913-918.
7. Gardosi J., Kady S.M., McGeown P., Francis A., Tonks A. Classification of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 2005, 331:1113-1117.
8. Chan P., Brown M., Simpson J.M., Davis G. Proteinuria in pre-eclampsia: how much matters?. BJOG 2005, 112:280-285.
9. Xiong X., Saunders L.D., Wang F.L., Davidge S.T., Buekens P. Preeclampsia and cerebral palsy in low-birth-weight and preterm infants: implications for the current " ischemic model" of preeclampsia. Hypertens Pregnancy 2001, 20:1-13.
10. Gul A., Cebeci A., Aslan H., Polat I., Ozdemir A., Ceylan Y. Perinatal outcomes in severe preeclampsia-eclampsia with and without HELLP syndrome. Gynecol Obstet Invest 2005, 59:113-118.
11. Ganzevoort W., Rep A., de Vries J.I., Bonsel G.J., Wolf H. Prediction of maternal complications and adverse infant outcome at admission for temporizing management of early-onset severe hypertensive disorders of pregnancy. Am J Obstet Gynecol 2006, 195:495-503. PETRA-investigators.
12. Cheng S.W., Chou H.C., Tsou K.I., Fang L.J., Tsao P.N. Delivery before 32 weeks of gestation for maternal preeclampsia: neonatal outcome and 2-year developmental outcome. Early Hum Dev 2004, 76:39-46.
13. Costeloe K., Hennessy E., Gibson A.T., Marlow N., Wilkinson A.R. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 2000, 106:659-671.
14. Tommiska V., Heinonen K., Ikonen S., Kero P., Pokela ml, Renlund M., et al. A national short-term follow-Up study of extremely lowbirth weight infants born in Finland in 1996-1997. Pediatrics 2001, 107:E2.
15. Markestad T., Kaaresen P.I., Rønnestad A., Reigstad H., Lossius K., Medbø S., et al. Early death, morbidity, and need of treatment among extremely premature infants. Pediatrics 2005, 115:1289-1298.
16. Hiett A.K., Brown H.L., Britton K.A. Outcome of infants delivered between 24 and 28 weeks'gestation in women with severe pre-eclampsia. J Matern Fetal Med 2001, 10:301-304.
17. Kurkinen-Räty M., Koivisto M., Jouppila P. Preterm delivery for maternal or fetal indications: maternal morbidity, neonatal outcome and late sequelae in infants. BJOG 2000, 107:648-655.
18. Bashiri A., Zmora E., Sheiner E., Hershkovitz R., Shoham-Vardi I., Mazor M. Maternal hypertensive disorders are an independent risk factor for the development of necrotizing enterocolitis in very low birth weight infants. Fetal Diagn Ther 2003, 18:404-407.
19. Habli M., Levine R.J., Qian C., Sibai B. Neonatal outcomes in pregnancies with preeclampsia or gestational hypertension and in normotensive pregnancies that delivered at 35, 36, or 37 weeks of gestation. Am J Obstet Gynecol 2007, 197. 406.e1-7.
20. Ancel P.Y., Livinec F., Larroque B., Marret S., Arnaud C., Pierrat V., et al. Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE cohort study. Pediatrics 2006, 117:828-835.
21. Murata Y., Itakura A., Matsuzawa K., Okumura A., Wakai K., Mizutani S. Possible antenatal and perinatal related factors in development of cystic periventricular leukomalacia. Brain Dev 2005, 27:17-21.
22. Spinillo A., Gardella B., Preti E., Zanchi S., Tzialla C., Stronati M. Preeclampsia and brain damage among preterm infants: a changed panorama in a 20-year analysis. Am J Perinatol 2007, 24:101-106.
23. Snijders R.J., De Courcy-Wheeler R.H., Nicolaides K.H. Intrauterine growth retardation and fetal transverse cerebellar diameter. Prenat Diagn 1994, 14:1101-1105.
24. Vinkesteijn A.S., Mulder P.G., Wladimiroff J.W. Fetal transverse cerebellar diameter measurements in normal and reduced fetal growth. Ultrasound Obstet Gynecol 2000, 15:47-51.
25. Dyet L.E., Kennea N., Counsell S.J., Maalouf E.F., Ajayi-Obe M., Duggan P.J., et al. Natural history of brain lesions in extremely preterm infants studied with serial magnetic resonance imaging from birth and neurodevelopmental assessment. Pediatrics 2006, 118:536-548.
26. Impey L., Greenwood C., Sheil O., MacQuillan K., Reynolds M., Redman C. The relation between pre-eclampsia at term and neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed 2001, 85:F170-F172.
27. Badawi N., Kurinczuk J.J., Keogh J.M., Alessandri L.M., O'Sullivan F., Burton P.R., et al. Antepartum risk factors fornewborn encephalopathy: the Western Australian case-control study. BMJ 1998, 317:1549-1553.
28. Zupan-Simunek V. Définition de l'asphyxie intrapartum et conséquences sur le devenir. J Gynecol Obstet Biol Reprod 2008, 37S:S7-15.
29. Hunt R.W., Badawi N., Laing S., Lam A. Pre-eclampsia: a predisposing factor for neonatal venous sinus thrombosis?. Pediatr Neurol 2001, 25:242-246.
30. Lee J., Croen L.A., Backstrand K.H., Yoshida C.K., Henning L.H., Lindan C., et al. Maternal and infant characteristics associated with perinatal arterial stroke in the infant. JAMA 2005, 293:723-729.
31. Rasmussen S., Irgens L.M. Fetal growth and body proportion in preeclampsia. Obstet Gynecol 2003, 101:575-583.
32. Juul S.E., Haynes J.W., McPherson R.J. Evaluation of neutropenia and neutrophilia in hospitalized preterm infants. J Perinatol 2004, 24:150-157.
33. Chakravorty S., Murray N., Roberts I. Neonatal thrombocytopenia. Early Hum Dev 2005, 81:35-41.
34. Christensen R.D., Henry E., Wiedmeier S.E., Stoddard R.A., Lambert D.K. Low blood neutrophil concentrations among extremely low birth weight neonates: data from a multihospital health-care system. J Perinatol 2006, 26:682-687.
35. Paul D.A., Leef K.H., Sciscione A., Tuttle D.J., Stefano J.L. Preeclampsia does not increase the risk for culture proven sepsis in very low birth weight infants. Am J Perinatol 1999, 16:365-372.
36. Teng R.J., Wu T.J., Sharma R., Garrison R.D., Hudak M.L. Early neonatal hypotension in premature infants born to preeclamptic mothers. J Perinatol 2006, 26:471-475.
37. Garza-Cox S., Keeney S.E., Angel C.A., Thompson L.L., Swischuk L.E. Meconium obstruction in the very low birth weight premature infant. Pediatrics 2004, 114:285-290.
38. Gray P.H., Jones P., O'Callaghan M.J. Maternal antecedents for cerebral palsy in extremely preterm babies: a case-control study. Dev Med Child Neurol 2001, 43:580-585.
39. Gray P.H., O'Callaghan M.J., Mohay H.A., Burns Y.R., King J.F. Maternal hypertension and neurodevelopmental outcome in very preterm infants. Arch Dis Child Fetal Neonatal Ed 1998, 79:F88-93.
40. Thorngren-Jerneck K., Herbst A. Perinatal factors associated with cerebral palsy in children born in Sweden. Obstet Gynecol 2006, 108:1499-1505.
41. Greenwood C., Yudkin P., Sellers S., Impey L., Doyle P. Why is there a modifying effect of gestational age on risk factors for cerebral palsy?. Arch Dis Child Fetal Neonatal Ed 2005, 90:F141-F146.
42. Vohr B.R., Wright L.L., Dusick A.M., Mele L., Verter J., Steichen J.J., et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000, 105:1216-1226.
43. Cooke R.W. Perinatal and postnatal factors in very preterm infants and subsequent cognitive and motor abilities. Arch Dis Child Fetal Neonatal Ed 2005, 90:F60-F63.
44. Barker D.J. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006, 49:270-283.
45. Dixon G., Badawi N., Kurinczuk J.J., Keogh J.M., Silburn S.R., Zubrick S.R., et al. Early developmental outcomes after newborn encephalopathy. Pediatrics 2002, 109:26-33.
46. Lindstrom K., Lagerroos P., Gillberg C., Fernell E. Teenage outcome after being born at term with moderate neonatal encephalopathy. Pediatr Neurol. 2006, 35:268-274.
47. Marlow N., Rose A.S., Rands C.E., Draper E.S. Neuropsychological and educational problems at school age associated with neonatal encephalopathy. Arch Dis Child Fetal Neonatal Ed 2005, 90:F380-F387.
48. Salomon O., Seligsohn U., Steinberg D.M., Zalel Y., Lerner A., Rosenberg N., et al. The common prothrombotic factors in nulliparous women do not compromise blood flow in the feto-maternal circulation and are not associated with preeclampsia or intrauterine growth restriction. Am J Obstet Gynecol 2004, 191:2002-2009.
49. Wilcken B., Leung K.C., Hammond J., Kamath R., Leonard J.V. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme A dehydrogenase deficiency. Lancet 1993, 341:407-408.
50. Ibdah J.A., Bennett M.J., Rinaldo P., Zhao Y., Gibson B., Sims H.F., et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999, 340:1723-1731.
51. Yang Z., Yamada J., Zhao Y., Strauss A.W., Ibdah J.A. Prospective screening for pediatric mitochondrial trifunctional protein defects in pregnancies complicated by liver disease. JAMA 2002, 288:2163-2166.
52. Mütze S., Ahillen I., Rudnik-Schoeneborn S., Eggermann T., Leeners B., Neumaier-Wagner P.M., et al. Neither maternal nor fetal mutation (E474Q) in the alpha-subunit of the trifunctional protein is frequent in pregnancies complicated by HELLP syndrome. J Perinat Med 2007, 35:76-78.
53. Hanff L.M., Vulto A.G., Bartels P.A., Roofthooft D.W., Bijvank B.N., Steegers E.A., et al. Intravenous use of the calcium-channel blocker nicardipine as second-line treatment in severe, early-onset pre-eclamptic patients. J Hypertens 2005, 23:2319-2326.
54. Nguon B., Zupan-Simunek V., Audibert F., Preaux N. Tocolyse par les inhibiteurs calciques et hémorragies intraventriculaires. J Gynecol Obstet Biol Reprod 2007, 36:287-292.
55. Bartels P.A., Hanff L.M., Mathot R.A., Steegers E.A., Vulto A.G., Visser W. Nicardipine in pre-eclamptic patients: placental transfer and disposition in breast milk. BJOG 2007, 114:230-233.
56. Cissoko H., Jonville-Béra A.P., Swortfiguer D., Giraudeau B., Autret-Leca E. Exposition aux bêtabloquants en fin de grossesse. Arch Pediatr 2005, 12:543-547.
57. Tabacova S., Kimmel C.A., Wall K., Hansen D. Atenolol developmental toxicity: animal-to-human comparisons. Birth Defects Res A Clin Mol Teratol 2003, 67:181-192.
58. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, 3. CD004454.
59. Baud O., Foix-L'Helias L., Kaminski M., Audibert F., Jarreau P.H., Papiernik E., et al. Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med 1999, 341:1190-1196.
60. Lee B.H., Stoll B.J., McDonald S.A., Higgins R.D. Adverse neonatal outcomes associated with antenatal dexamethasone versus antenatal betamethasone. Pediatrics 2006, 117:1503-1510. National Institute of Child Health and Human Development Neonatal Research Network.
61. Isler C.M., Magann E.F., Rinehart B.K., Terrone D.A., Bass J.D., Martin J.N. Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome. Int J Gynaecol Obstet 2003, 80:291-297.
62. Matchaba P., Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 2004, 1. CD002076.
63. van Runnard Heimel P.J., Schobben A.F., Huisjes A.J., Franx A., Bruinse H.W. The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome. Placenta 2005, 26:842-845.
64. Altman D., Carroli G., Duley L., Farrell B., Moodley J., Neilson J., et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002, 359:1877-1890.
65. Duley L., Gülmezoglu A.M., Henderson-Smart D.J. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2003, 2. CD000025.
66. Duley L., Henderson-Smart D.J., Meher S., King J.F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007, 18:CD004659.
67. Askie L.M., Duley L., Henderson-Smart D.J., Stewart L.A. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007, 26:1791-1798. PARIS Collaborative Group.